Meniscal Repair Biologic Augmentation: Marrow Venting Procedure Versus PRP (MVP Trial)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Meniscal Tear
-
Age: Between 18 Year(s) - 55 Year(s)
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Medial, lateral, vertical longitudinal, oblique, or radial meniscal tear
- Complex tears may be included at the discretion of the investigator if patient has one of tear patterns as the most predominant finding
- No other concomitant procedure unless one of the following:
- Chondroplasty
- Synovectomy
- Loose body removal
- "Contralateral" meniscectomy
- Any other procedure that does not include drilling, requires prior approval of the study sponsor for each procedure
You may not be eligible for this study if the following are true:
-
- Patients requiring cartilage restorative or repair procedures
- Patients with meniscus root tears
- Patients undergoing repair for predominant horizontal cleavage tears
- Patients undergoing lateral release
- Ipsilateral chondral lesion with Outerbridge classification of 3-4
- Use of prednisone or other steroids, any immunosuppressant, or chemotherapy 1-week before surgery or expected use within six weeks after surgery
- Cortisone use within the six weeks prior to surgery
- Utilizing worker's compensation at the time of screening
- Any previous ligament surgery on the index limb. Any previous meniscal surgery on the index meniscus.
- Concomitant ligamentous insufficiency
- Inflammatory rheumatic disease or other rheumatic disease
- Immune compromised patients (hepatitis, HIV, etc.)
- Any nicotine based products within the three months prior to surgery (including cigarettes, cigars, vaping, nicotine patch, etc)
- History of distal femur, proximal tibia, or patellar fracture that was treated operatively
- Non English-speaking patients
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.